Diphtheria Toxoid + Haemophilus Influenza Type B Polyribose Ribitol Phosphate + Hepatitis B Surface Antigen + Pertactin + Pertussis Filamentous Haemagglutinin + Pertussis Fimbriae 2 + 3 + Pertussis Toxoid + Poliovirus + Tetanus Toxoid
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Diphtheria Toxoid
diphtheria-toxoid - Haemophilus Influenza Type B Polyribose Ribitol Phosphate
haemophilus-influenza-type-b-polyribose-ribitol-phosphate - Hepatitis B Surface Antigen
hepatitis-b-surface-antigen - Pertactin
pertactin - Pertussis Filamentous Haemagglutinin
pertussis-filamentous-haemagglutinin - Pertussis Fimbriae 2 + 3
pertussis-fimbriae-2-3 - Pertussis Toxoid
pertussis-toxoid - Poliovirus
poliovirus - Tetanus Toxoid
tetanus-toxoid
Brands with this exact combination
| Brand | Composition & strength | Manufacturer |
|---|---|---|
| VaxelisAU CZ EU LV |
| MCM Vaccine B.V., Netherlands |
| pertussis filamentous haemagglutinin + pertussis toxoid + pertactin + hepatitis b surface antigen + diphtheria toxoid + tetanus toxoid + haemophilus influenza type b polyribose ribitol phosphate + poliovirus + pertussis fimbriae 2 + 3AU | — | — |
| VAXELIS DTPa5-HepB-IPV-Hib vaccine suspension for injection in 0.5 mL pre-filled syringeAU |
| Maxx Pharma Pty Ltd |
Same combination in other markets
Cross-market comparison is not available for this grouped name.
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.